Browsing Tag
Johnson & Johnson
103 posts
Johnson & Johnson’s TAR-200 delivers over 80% disease-free survival, offering new hope in BCG-unresponsive high-risk papillary NMIBC
Discover how Johnson & Johnson’s TAR-200 is redefining bladder cancer treatment with over 80% disease-free survival and 94% bladder preservation today!
Why did Corcept, Johnson & Johnson, and Southwest Airlines fall on April 1, 2025?
Corcept, Johnson & Johnson, and Southwest Airlines lead US stock losses as biotech and airline sectors react to trade policy jitters on April 1, 2025.
Johnson & Johnson’s $55bn bet: What it means for healthcare and investors
Johnson & Johnson is investing $55 billion in U.S. manufacturing, R&D, and technology, reinforcing its leadership in pharmaceuticals. Find out more.
Johnson & Johnson’s icotrokinra demonstrates superiority in plaque psoriasis trials, setting stage for market disruption
New clinical trial data from Johnson & Johnson suggests that icotrokinra results could mark a major shift in…
Janssen’s subcutaneous amivantamab gains CHMP backing for EGFR-mutated lung cancer
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a…
Johnson & Johnson to acquire Intra-Cellular Therapies in $14.6bn deal
Johnson & Johnson has announced its largest biotech acquisition in over a year, agreeing to purchase Intra-Cellular Therapies…
Johnson & Johnson’s RYBREVANT and LAZCLUZE show unprecedented survival advantage in lung cancer trial
Johnson & Johnson has revealed transformative results from the Phase 3 MARIPOSA clinical trial, positioning the combination of…
Biotech breakthrough: Mersana Therapeutics stock soars 23% after blowing past Q3 expectations
Mersana Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing antibody-drug conjugates (ADCs) for cancer treatment, saw its…
FDA greenlights Medtronic’s dual-energy ablation—could this be the future of AFib treatment?
Medtronic has achieved a major milestone with the U.S. Food and Drug Administration (FDA) granting approval for its…
Indoco Remedies secures final USFDA approval for generic Cetirizine Hydrochloride tablets
Indoco Remedies Limited has secured a significant regulatory win by receiving final approval from the United States Food…